Adverse events and efficacy of second-round CAR-T cell therapy in relapsed pediatric B-ALL. Ji Q, Wu X, Zhang Y, Zeng L, et al. Eur J Haematol 2024;112:75-82.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ji Q, Wu X, Zhang Y, Zeng L, et al. Adverse events and efficacy of second-round CAR-T cell therapy in relapsed pediatric B-ALL. Eur J Haematol 2024;112:75-82.
PMID: 37649264